FFO
CGEM icon

Fortitude Family Office’s Cullinan Oncology CGEM Stock Holding History

Fortitude Family Office’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5K Hold
192
– – ﹤0.01% 1247
2026
Q1 		$2.73K Buy
192
+134
+231% +$1.72K ﹤0.01% 1161
2025
Q4 		$600 Buy
+58
New +$523 ﹤0.01% 1636

Other funds holding CGEM

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Fortitude Family Office's CGEM Position: Q2 2026 in Review

Fortitude Family Office held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 192 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Fortitude Family Office first reported a position in CGEM in Q4 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Fortitude Family Office held 192 shares of Cullinan Oncology worth $3.5K as of Q2 2026.
  • Fortitude Family Office left its Cullinan Oncology share count unchanged in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1247 holding.
  • Fortitude Family Office first reported a position in Cullinan Oncology in Q4 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.